Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis.

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationAll authors agree to publish. Competing interestsThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

"Funding This study was supported by the Instituto de Salud Carlos III (ISCIII) through the project grants PI19/00560, PI22/00167 and CIBERONC (CB16/12/00390) and co-funded by the European Union, the Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Fundación Bancaria Cajastur-IUOPA, and Universidad de Oviedo. Additional funding was provided through the grant “Ayudas para Grupos de Investigación de Organismos del Principado de Asturias 2021–2023” (IDI/2021/000079), funded by Principado de Asturias through FICYT and the FEDER Funding Program from the European Union. FH-P is recipient of a Maria Zambrano grant at the University of Oviedo, and MO-R is recipient of a PFIS predoctoral fellowship from ISCIII (FI23/00037)."